HDAC6 and pemphigus foliaceus: in a PDF-induced PF mouse model, administered the selective HDAC6 inhibitor tubastatin A (TA) to inhibit TGF-β1-induced EMT in PMCs, reduce the expression of collagen I and α-SMA, and prevent fibrosis in the mouse model.